Delivery Order SPE2DX22D0010-SPE2D823FPH16

Award Date 7/19/23
Potential Completion Date 7/20/23
Potential Value $38K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,671.84 for the supply of Vyvanse 30 mg capsule. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,684.66, is for the delivery of Vyvanse 40mg capsules to support federal healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $60,892.57 for the supply of Vyvanse capsules 40mg. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract has an ultimate completion date of May 5, 2023 and is a firm fixed-price arrangement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB21FP01U) valued at $15,301.92 for the supply of Vyvanse 60 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the Department of...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (DO) valued at $5,211.56 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of Vyvanse 40 mg capsules to support military healthcare programs. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical to supply a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $3,921.27 delivery order for the supply of Vyvanse 20 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 8, 2023. Amerisourcebergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems....
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, including Vyvanse 50 mg capsules, to support government healthcare programs. The $4,628.64 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of March 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FV6A4) valued at $1,271.42 for the supply of Vyvanse 20 mg capsules. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,479.88, is for the delivery of Vyvanse capsules 40mg. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of January 31, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical under a $2,190.10 delivery order. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support the...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D823FPH16
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $38,387.15 for the supply of Vyvanse capsules 40mg. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and does not have a set-aside designation.

Amerisourcebergen is a major pharmaceutical distributor that holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00 respectively. These IDCs enable Amerisourcebergen to efficiently provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, and medical devices, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:21 AM